Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel integrin receptor antagonists from DuPont Merck

Sep. 8, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

AccuSite approved in Ireland and The Netherlands

Sep. 4, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Cloning of telomerase catalytic subunit reported

Sep. 3, 1997

Merck & Co. describes nonsteroidal antiandrogen

Sep. 3, 1997

U.S. clearance for Femara

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...